IBI-305

URI: https://gptkb.org/entity/IBI-305
GPTKB entity
Statements (13)
Predicate Object
gptkbp:instanceOf gptkb:monoclonal_antibody
gptkbp:approvedBy gptkb:China
gptkbp:ATCCode L01XC07
gptkbp:biosimilar gptkb:bevacizumab
gptkbp:clinicalTrialPhase Phase 3
gptkbp:developedBy gptkb:Innovent_Biologics
https://www.w3.org/2000/01/rdf-schema#label IBI-305
gptkbp:mechanismOfAction inhibits angiogenesis
gptkbp:routeOfAdministration intravenous
gptkbp:target gptkb:VEGF
gptkbp:usedFor gptkb:cancer
gptkbp:bfsParent gptkb:Suzhou_Innovent_Biologics
gptkbp:bfsLayer 7